Inhibitex, Inc.
Inhibitex Reports Fourth Quarter and Calendar Year 2008 Financial Results and Highlights
Published in Hepatitis Weekly, March 23rd, 2009
“We are pleased with the progress we have made over the last year, resulting in the achievement of three primary goals,” stated Russell H. Plumb, President and CEO of Inhibitex, Inc. “These goals were to successfully complete our Phase I program for FV-100, identify a lead candidate from our series of HCV nucleoside polymerase inhibitors for further preclinical development, and reduce our overhead costs to extend our cash runway in this challenging business environment. Accordingly, we believe we are well positioned to move our development programs to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-03-23)
More Articles from Hepatitis Weekly
- Scripps Research Institute
Scripps research team identifies key molecules that inhibit viral production - Wiley-Blackwell
Liver transplant recipients with hepatitis B may need lifelong antiviral treatment - Acute Hepatitis
Data from Y. Radhakrishna and colleagues advance knowledge in acute hepatitis - Acute Hepatitis
Research results from University of New South Wales update knowledge of acute hepatitis - Chronix Biomedical
Chronix Biomedical Says Three Recent Studies Support the Utility of Circulating DNA as Novel Diagnostics for Human Cancer, Mad Cow Disease and Other Conditions - Hepatitis
Researchers from Aga Khan University provide details of new studies and findings in the area of hepatitis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
